Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The M2-1 protein is a critical transcription elongation factor encoded by the respiratory syncytial virus (RSV). It is essential for efficient viral mRNA synthesis, particularly for the production of full-length and polycistronic mRNAs during infection. It acts as a transcription antitermination factor, enabling the viral RNA-dependent RNA polymerase to synthesize complete mRNAs by preventing premature termination at gene end signals. M2–1 is indispensable for processive transcription but not required for genome replication.
Prevents premature termination by masking gene-end signals
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Respiratory syncytial virus transcription elongation factor M2–1 (None).